Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 42 | 2023 | 20448 | 2.700 |
Why?
|
Oxidative Stress | 31 | 2022 | 3094 | 2.530 |
Why?
|
Pesticides | 4 | 2023 | 283 | 2.350 |
Why?
|
Nitric Oxide | 25 | 2020 | 2101 | 1.520 |
Why?
|
Glutathione Transferase | 2 | 2021 | 602 | 1.320 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 2020 | 267 | 1.300 |
Why?
|
Arachidonate 5-Lipoxygenase | 2 | 2019 | 145 | 1.050 |
Why?
|
Carcinoma, Ductal, Breast | 6 | 2021 | 1096 | 1.020 |
Why?
|
Receptor, erbB-2 | 7 | 2022 | 2334 | 0.990 |
Why?
|
Oxidation-Reduction | 10 | 2022 | 2192 | 0.960 |
Why?
|
Chagas Disease | 3 | 2020 | 163 | 0.890 |
Why?
|
Atrazine | 1 | 2022 | 9 | 0.880 |
Why?
|
Proteomics | 9 | 2019 | 3446 | 0.880 |
Why?
|
Nitric Oxide Synthase Type II | 8 | 2020 | 536 | 0.870 |
Why?
|
Agricultural Workers' Diseases | 1 | 2022 | 29 | 0.860 |
Why?
|
Pesticide Residues | 1 | 2023 | 92 | 0.850 |
Why?
|
Antioxidants | 9 | 2022 | 1673 | 0.840 |
Why?
|
Brazil | 7 | 2023 | 1222 | 0.820 |
Why?
|
Leishmania | 5 | 2021 | 63 | 0.800 |
Why?
|
Lipid Peroxidation | 15 | 2022 | 294 | 0.770 |
Why?
|
Doxorubicin | 5 | 2021 | 2224 | 0.760 |
Why?
|
Antiprotozoal Agents | 5 | 2019 | 87 | 0.750 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2023 | 1028 | 0.750 |
Why?
|
Plant Leaves | 1 | 2020 | 142 | 0.740 |
Why?
|
Trypanosoma cruzi | 6 | 2020 | 196 | 0.740 |
Why?
|
Paclitaxel | 5 | 2021 | 1685 | 0.730 |
Why?
|
Reactive Oxygen Species | 11 | 2022 | 2078 | 0.660 |
Why?
|
Hospital Records | 1 | 2018 | 97 | 0.640 |
Why?
|
Leishmaniasis, Cutaneous | 4 | 2021 | 121 | 0.590 |
Why?
|
Peroxidase | 1 | 2020 | 618 | 0.580 |
Why?
|
Mass Spectrometry | 5 | 2016 | 2222 | 0.580 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2017 | 623 | 0.580 |
Why?
|
Macrophages, Peritoneal | 5 | 2020 | 261 | 0.570 |
Why?
|
Neoplasms | 9 | 2023 | 20947 | 0.560 |
Why?
|
Caffeine | 1 | 2020 | 692 | 0.550 |
Why?
|
Cytokines | 12 | 2023 | 7187 | 0.550 |
Why?
|
NF-kappa B | 3 | 2023 | 2549 | 0.540 |
Why?
|
Autoimmunity | 2 | 2020 | 1320 | 0.530 |
Why?
|
Lipid Peroxides | 4 | 2023 | 73 | 0.520 |
Why?
|
Occupational Exposure | 2 | 2023 | 1781 | 0.520 |
Why?
|
Pain, Intractable | 1 | 2015 | 130 | 0.510 |
Why?
|
Acute-Phase Proteins | 1 | 2015 | 265 | 0.500 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 200 | 0.490 |
Why?
|
Prognosis | 16 | 2023 | 28718 | 0.480 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2023 | 8453 | 0.470 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1761 | 0.470 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3335 | 0.460 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 508 | 0.440 |
Why?
|
Interleukin-12 | 3 | 2023 | 593 | 0.440 |
Why?
|
Propolis | 3 | 2016 | 8 | 0.430 |
Why?
|
Metformin | 4 | 2020 | 805 | 0.400 |
Why?
|
Adiponectin | 2 | 2014 | 1087 | 0.390 |
Why?
|
Down-Regulation | 3 | 2020 | 3026 | 0.370 |
Why?
|
Proteome | 3 | 2015 | 1768 | 0.370 |
Why?
|
Chagas Cardiomyopathy | 1 | 2010 | 71 | 0.370 |
Why?
|
Concanavalin A | 2 | 2020 | 196 | 0.360 |
Why?
|
Female | 63 | 2023 | 375303 | 0.360 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2020 | 5169 | 0.360 |
Why?
|
Transforming Growth Factor beta | 3 | 2015 | 1996 | 0.350 |
Why?
|
Models, Cardiovascular | 1 | 2014 | 996 | 0.350 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1967 | 0.340 |
Why?
|
Leukotrienes | 1 | 2010 | 260 | 0.340 |
Why?
|
Leishmania braziliensis | 2 | 2019 | 15 | 0.330 |
Why?
|
Humans | 72 | 2023 | 725001 | 0.320 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 855 | 0.310 |
Why?
|
Anti-Inflammatory Agents | 2 | 2016 | 1753 | 0.310 |
Why?
|
Transforming Growth Factor beta1 | 4 | 2020 | 652 | 0.310 |
Why?
|
Protein Carbonylation | 4 | 2015 | 33 | 0.310 |
Why?
|
Neutrophils | 1 | 2020 | 3729 | 0.300 |
Why?
|
Leishmaniasis | 2 | 2017 | 46 | 0.300 |
Why?
|
Glutathione | 4 | 2021 | 592 | 0.300 |
Why?
|
Chromatography, Liquid | 3 | 2015 | 975 | 0.290 |
Why?
|
Breast | 1 | 2015 | 1914 | 0.290 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 2005 | 0.290 |
Why?
|
DNA Damage | 3 | 2017 | 2465 | 0.270 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2163 | 0.270 |
Why?
|
Antineoplastic Agents | 7 | 2022 | 13563 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 8896 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17328 | 0.260 |
Why?
|
Ruthenium Compounds | 2 | 2016 | 8 | 0.250 |
Why?
|
Malondialdehyde | 5 | 2015 | 112 | 0.250 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4755 | 0.250 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2015 | 3877 | 0.250 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2973 | 0.250 |
Why?
|
Cell Line, Tumor | 12 | 2023 | 16634 | 0.250 |
Why?
|
Neoplasm Proteins | 2 | 2015 | 3708 | 0.240 |
Why?
|
Neoplasm Staging | 8 | 2023 | 10926 | 0.240 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2023 | 4409 | 0.240 |
Why?
|
Hematocrit | 1 | 2005 | 633 | 0.240 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 64 | 0.230 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2019 | 686 | 0.230 |
Why?
|
Erythrocytes | 5 | 2015 | 2424 | 0.230 |
Why?
|
Wedelia | 1 | 2022 | 1 | 0.230 |
Why?
|
Middle Aged | 33 | 2022 | 212155 | 0.230 |
Why?
|
Arthritis, Gouty | 1 | 2022 | 28 | 0.230 |
Why?
|
Aldrin | 1 | 2022 | 2 | 0.220 |
Why?
|
Trifluralin | 1 | 2022 | 2 | 0.220 |
Why?
|
Diuron | 1 | 2022 | 4 | 0.220 |
Why?
|
Chlordan | 1 | 2022 | 5 | 0.220 |
Why?
|
Dieldrin | 1 | 2022 | 8 | 0.220 |
Why?
|
Rats, Wistar | 8 | 2022 | 1899 | 0.220 |
Why?
|
DDT | 1 | 2022 | 32 | 0.220 |
Why?
|
Interleukin-4 | 2 | 2023 | 1159 | 0.220 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3596 | 0.220 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 72 | 0.220 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2022 | 88 | 0.210 |
Why?
|
Mice, Inbred BALB C | 11 | 2021 | 6440 | 0.210 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4171 | 0.210 |
Why?
|
Signal Transduction | 11 | 2019 | 23445 | 0.200 |
Why?
|
Chalcone | 1 | 2020 | 9 | 0.200 |
Why?
|
Cell Proliferation | 8 | 2022 | 10472 | 0.200 |
Why?
|
Animals | 33 | 2022 | 168735 | 0.200 |
Why?
|
Chalcones | 1 | 2020 | 27 | 0.200 |
Why?
|
Medulla Oblongata | 1 | 2022 | 242 | 0.190 |
Why?
|
Leukocytes, Mononuclear | 2 | 2018 | 1803 | 0.190 |
Why?
|
Inflammation Mediators | 4 | 2021 | 1891 | 0.190 |
Why?
|
Inflammation | 9 | 2021 | 10337 | 0.190 |
Why?
|
Glutathione S-Transferase pi | 1 | 2020 | 96 | 0.190 |
Why?
|
Halogenation | 1 | 2020 | 41 | 0.190 |
Why?
|
Research Report | 1 | 2023 | 353 | 0.190 |
Why?
|
DNA Modification Methylases | 1 | 2021 | 208 | 0.190 |
Why?
|
Stress, Psychological | 1 | 2015 | 4160 | 0.180 |
Why?
|
Carcinoma | 1 | 2011 | 2337 | 0.180 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 159 | 0.180 |
Why?
|
Diterpenes | 2 | 2022 | 185 | 0.180 |
Why?
|
Adult | 28 | 2022 | 211523 | 0.180 |
Why?
|
Obesity | 4 | 2017 | 12420 | 0.180 |
Why?
|
Hypertension | 5 | 2022 | 8250 | 0.170 |
Why?
|
Molecular Targeted Therapy | 4 | 2020 | 2759 | 0.170 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2016 | 511 | 0.170 |
Why?
|
Triclosan | 1 | 2019 | 52 | 0.170 |
Why?
|
Leishmania mexicana | 2 | 2015 | 31 | 0.170 |
Why?
|
Aged | 18 | 2022 | 161379 | 0.170 |
Why?
|
Sodium Glutamate | 3 | 2017 | 27 | 0.170 |
Why?
|
Quercetin | 1 | 2019 | 94 | 0.170 |
Why?
|
Proteins | 1 | 2014 | 6084 | 0.170 |
Why?
|
Tumor Escape | 1 | 2021 | 346 | 0.170 |
Why?
|
Ascorbic Acid | 1 | 2022 | 650 | 0.170 |
Why?
|
HIV-1 | 2 | 2015 | 6854 | 0.160 |
Why?
|
Axilla | 1 | 2020 | 574 | 0.160 |
Why?
|
Lung Neoplasms | 2 | 2022 | 12874 | 0.160 |
Why?
|
Monoterpenes | 1 | 2017 | 18 | 0.150 |
Why?
|
Pharmacogenetics | 1 | 2022 | 673 | 0.150 |
Why?
|
1,2-Dimethylhydrazine | 1 | 2016 | 8 | 0.150 |
Why?
|
Melatonin | 1 | 2023 | 713 | 0.150 |
Why?
|
Superoxide Dismutase | 3 | 2022 | 611 | 0.150 |
Why?
|
Silver | 1 | 2017 | 117 | 0.150 |
Why?
|
Aberrant Crypt Foci | 1 | 2016 | 11 | 0.150 |
Why?
|
Blotting, Western | 2 | 2015 | 5237 | 0.150 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2018 | 222 | 0.150 |
Why?
|
Early Detection of Cancer | 2 | 2021 | 2958 | 0.150 |
Why?
|
Cell Polarity | 1 | 2020 | 651 | 0.150 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 246 | 0.150 |
Why?
|
Nitroso Compounds | 1 | 2016 | 73 | 0.150 |
Why?
|
Paraneoplastic Polyneuropathy | 1 | 2015 | 3 | 0.140 |
Why?
|
Sympathetic Nervous System | 2 | 2022 | 519 | 0.140 |
Why?
|
Trypanocidal Agents | 1 | 2016 | 36 | 0.140 |
Why?
|
Gout | 1 | 2022 | 554 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2013 | 2074 | 0.140 |
Why?
|
Guanidines | 1 | 2017 | 196 | 0.140 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3601 | 0.140 |
Why?
|
Nitroprusside | 1 | 2016 | 278 | 0.140 |
Why?
|
Nitrates | 2 | 2015 | 265 | 0.140 |
Why?
|
Apoptosis | 7 | 2022 | 9754 | 0.140 |
Why?
|
Fetal Growth Retardation | 1 | 2019 | 559 | 0.130 |
Why?
|
Immunohistochemistry | 6 | 2016 | 11486 | 0.130 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 162 | 0.130 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 10879 | 0.130 |
Why?
|
Genomics | 2 | 2022 | 5562 | 0.130 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 101 | 0.130 |
Why?
|
beta Catenin | 1 | 2020 | 1057 | 0.130 |
Why?
|
Interleukin-1beta | 3 | 2015 | 949 | 0.130 |
Why?
|
Genetic Heterogeneity | 2 | 2015 | 736 | 0.130 |
Why?
|
Nitric Oxide Donors | 1 | 2015 | 122 | 0.130 |
Why?
|
Uterus | 1 | 2019 | 692 | 0.130 |
Why?
|
Myoblasts, Cardiac | 1 | 2014 | 23 | 0.130 |
Why?
|
Catalase | 2 | 2014 | 233 | 0.130 |
Why?
|
Disease Progression | 3 | 2021 | 13161 | 0.130 |
Why?
|
Brain Neoplasms | 1 | 2016 | 8644 | 0.130 |
Why?
|
Carcinoma, Ductal | 1 | 2015 | 104 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2935 | 0.130 |
Why?
|
Cyclooxygenase 1 | 1 | 2014 | 107 | 0.120 |
Why?
|
Indomethacin | 1 | 2015 | 334 | 0.120 |
Why?
|
Vitamin D | 2 | 2020 | 3177 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2015 | 1589 | 0.120 |
Why?
|
Interleukin-17 | 1 | 2020 | 873 | 0.120 |
Why?
|
Cyclooxygenase 2 | 2 | 2014 | 608 | 0.120 |
Why?
|
Ferritins | 2 | 2015 | 582 | 0.120 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 227 | 0.120 |
Why?
|
Acute Disease | 2 | 2017 | 7090 | 0.120 |
Why?
|
Mice | 16 | 2021 | 80318 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 570 | 0.120 |
Why?
|
Albumins | 1 | 2016 | 564 | 0.120 |
Why?
|
Statistics, Nonparametric | 3 | 2013 | 2896 | 0.110 |
Why?
|
Enzyme Inhibitors | 4 | 2021 | 3821 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2017 | 400 | 0.110 |
Why?
|
Glycerol | 1 | 2014 | 275 | 0.110 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 638 | 0.110 |
Why?
|
Case-Control Studies | 7 | 2020 | 21575 | 0.110 |
Why?
|
Maternal Exposure | 1 | 2019 | 935 | 0.110 |
Why?
|
Homocysteine | 1 | 2015 | 642 | 0.110 |
Why?
|
Immunomodulation | 2 | 2016 | 524 | 0.110 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2011 | 45 | 0.110 |
Why?
|
Metabolism, Inborn Errors | 1 | 2014 | 278 | 0.110 |
Why?
|
Drug Therapy | 1 | 2015 | 497 | 0.110 |
Why?
|
Oxidants | 1 | 2012 | 168 | 0.100 |
Why?
|
Paracoccidioidomycosis | 1 | 2011 | 9 | 0.100 |
Why?
|
HIV Infections | 2 | 2015 | 16214 | 0.100 |
Why?
|
Rats | 9 | 2022 | 24422 | 0.100 |
Why?
|
Glycosylation | 1 | 2014 | 1108 | 0.100 |
Why?
|
Iron | 3 | 2019 | 1713 | 0.100 |
Why?
|
Area Under Curve | 1 | 2015 | 1660 | 0.100 |
Why?
|
Tyrosine | 1 | 2016 | 1471 | 0.100 |
Why?
|
Rural Population | 1 | 2022 | 2174 | 0.100 |
Why?
|
Heart Rate | 5 | 2022 | 4068 | 0.100 |
Why?
|
Nitrites | 1 | 2011 | 162 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2691 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 782 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15404 | 0.100 |
Why?
|
Skin | 2 | 2016 | 4311 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11303 | 0.100 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6881 | 0.100 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1962 | 0.090 |
Why?
|
Mice, Knockout | 2 | 2019 | 14770 | 0.090 |
Why?
|
Cell Movement | 2 | 2020 | 5284 | 0.090 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 14701 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2021 | 2943 | 0.090 |
Why?
|
Interferon-gamma | 1 | 2018 | 3221 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3635 | 0.090 |
Why?
|
Male | 25 | 2022 | 346964 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 933 | 0.080 |
Why?
|
Cytoskeletal Proteins | 1 | 2014 | 1384 | 0.080 |
Why?
|
Th1 Cells | 1 | 2013 | 1061 | 0.080 |
Why?
|
Th2 Cells | 1 | 2013 | 1052 | 0.080 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2010 | 322 | 0.080 |
Why?
|
ROC Curve | 1 | 2015 | 3491 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2761 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2014 | 3178 | 0.080 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 677 | 0.080 |
Why?
|
Hepatitis C, Chronic | 1 | 2015 | 1013 | 0.080 |
Why?
|
Parasitemia | 2 | 2020 | 174 | 0.080 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2019 | 2354 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4314 | 0.070 |
Why?
|
Antifungal Agents | 1 | 2011 | 715 | 0.070 |
Why?
|
Immunotherapy | 1 | 2021 | 4257 | 0.070 |
Why?
|
Homeostasis | 2 | 2015 | 3330 | 0.070 |
Why?
|
Endotoxemia | 1 | 2007 | 205 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2011 | 966 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5198 | 0.070 |
Why?
|
Cell Survival | 4 | 2017 | 5908 | 0.070 |
Why?
|
Genotype | 1 | 2020 | 12882 | 0.070 |
Why?
|
Aspirin | 2 | 2014 | 3209 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2018 | 3354 | 0.070 |
Why?
|
Osmotic Pressure | 1 | 2005 | 154 | 0.060 |
Why?
|
Diet | 1 | 2023 | 7797 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 2007 | 427 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7835 | 0.060 |
Why?
|
Autonomic Nervous System | 2 | 2022 | 671 | 0.060 |
Why?
|
Nitric Oxide Synthase | 1 | 2007 | 920 | 0.060 |
Why?
|
Blood Pressure | 4 | 2022 | 8464 | 0.060 |
Why?
|
gamma-Glutamyltransferase | 2 | 2015 | 133 | 0.060 |
Why?
|
Myocardium | 3 | 2017 | 4811 | 0.060 |
Why?
|
Survival Analysis | 2 | 2014 | 10244 | 0.060 |
Why?
|
Overweight | 1 | 2015 | 2285 | 0.060 |
Why?
|
Autophagy | 2 | 2022 | 1301 | 0.060 |
Why?
|
Cohort Studies | 3 | 2015 | 39883 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2512 | 0.060 |
Why?
|
Postmenopause | 1 | 2012 | 2440 | 0.060 |
Why?
|
Macrophages | 4 | 2021 | 5693 | 0.060 |
Why?
|
Cell Size | 1 | 2005 | 645 | 0.060 |
Why?
|
Disabled Persons | 1 | 2012 | 1150 | 0.060 |
Why?
|
Thiohydantoins | 1 | 2022 | 20 | 0.050 |
Why?
|
Lactates | 1 | 2023 | 419 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 5041 | 0.050 |
Why?
|
Bone Marrow | 1 | 2012 | 2909 | 0.050 |
Why?
|
Fishes | 1 | 2005 | 565 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6527 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6158 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2482 | 0.050 |
Why?
|
Arginase | 1 | 2021 | 74 | 0.050 |
Why?
|
Receptors, Estrogen | 3 | 2015 | 2167 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4512 | 0.050 |
Why?
|
Risk Assessment | 1 | 2023 | 23178 | 0.050 |
Why?
|
Dinoprostone | 2 | 2017 | 594 | 0.050 |
Why?
|
Body Mass Index | 2 | 2015 | 12527 | 0.050 |
Why?
|
Histocompatibility Antigens | 1 | 2021 | 472 | 0.050 |
Why?
|
Pyrimidines | 1 | 2012 | 2895 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 14955 | 0.050 |
Why?
|
Up-Regulation | 2 | 2020 | 4234 | 0.050 |
Why?
|
Chronic Disease | 1 | 2015 | 9026 | 0.050 |
Why?
|
Heart | 2 | 2010 | 4367 | 0.050 |
Why?
|
Young Adult | 3 | 2018 | 55791 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2018 | 5066 | 0.050 |
Why?
|
Ganglia, Spinal | 1 | 2022 | 525 | 0.050 |
Why?
|
Incidence | 1 | 2018 | 20743 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2021 | 462 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18040 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2021 | 464 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2021 | 285 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 19487 | 0.040 |
Why?
|
Estrous Cycle | 1 | 2019 | 72 | 0.040 |
Why?
|
Prospective Studies | 2 | 2014 | 51853 | 0.040 |
Why?
|
Risk Factors | 3 | 2022 | 70971 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3872 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2021 | 578 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2021 | 930 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5357 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4171 | 0.040 |
Why?
|
Leukapheresis | 1 | 2018 | 125 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1111 | 0.040 |
Why?
|
Liver | 4 | 2015 | 7505 | 0.040 |
Why?
|
Uric Acid | 2 | 2014 | 756 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 582 | 0.040 |
Why?
|
Motor Activity | 1 | 2007 | 2714 | 0.040 |
Why?
|
Phenotype | 1 | 2014 | 16262 | 0.040 |
Why?
|
Lactation | 1 | 2019 | 409 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6672 | 0.040 |
Why?
|
Thyroid Hormones | 1 | 2019 | 383 | 0.040 |
Why?
|
Nitrosation | 1 | 2016 | 27 | 0.040 |
Why?
|
Phagocytes | 1 | 2018 | 300 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57615 | 0.040 |
Why?
|
Heme Oxygenase-1 | 1 | 2019 | 376 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9375 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2512 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2019 | 360 | 0.040 |
Why?
|
Mutation | 1 | 2020 | 29645 | 0.030 |
Why?
|
Meglumine | 1 | 2015 | 147 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 682 | 0.030 |
Why?
|
Cell Membrane | 1 | 2005 | 3814 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2019 | 894 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2022 | 791 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2015 | 426 | 0.030 |
Why?
|
Transforming Growth Factor alpha | 1 | 2014 | 134 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22139 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 420 | 0.030 |
Why?
|
Anemia | 2 | 2015 | 1466 | 0.030 |
Why?
|
Erythrocyte Count | 1 | 2014 | 165 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 2015 | 296 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2014 | 255 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 40178 | 0.030 |
Why?
|
Fetal Development | 1 | 2019 | 748 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2019 | 1205 | 0.030 |
Why?
|
Sulfonamides | 2 | 2014 | 1883 | 0.030 |
Why?
|
Hindlimb | 1 | 2015 | 537 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2016 | 615 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 595 | 0.030 |
Why?
|
Dinoprost | 1 | 2013 | 142 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1544 | 0.030 |
Why?
|
Lung | 3 | 2022 | 9812 | 0.030 |
Why?
|
Pyrazoles | 2 | 2014 | 1926 | 0.030 |
Why?
|
Luminescence | 1 | 2012 | 110 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1611 | 0.030 |
Why?
|
Mediator Complex | 1 | 2012 | 101 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2015 | 657 | 0.030 |
Why?
|
Paracoccidioides | 1 | 2011 | 2 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2015 | 3692 | 0.030 |
Why?
|
Rodent Diseases | 1 | 2011 | 73 | 0.020 |
Why?
|
X-Rays | 1 | 2011 | 294 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3466 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 698 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2016 | 1297 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12244 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1799 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1668 | 0.020 |
Why?
|
Phagocytosis | 1 | 2016 | 1574 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13356 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2011 | 340 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3739 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2011 | 733 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1892 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 24043 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4887 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2022 | 3584 | 0.020 |
Why?
|
Fluorescence | 1 | 2011 | 753 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5934 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1568 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2012 | 740 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1367 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2980 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10246 | 0.020 |
Why?
|
Anthropometry | 1 | 2013 | 1356 | 0.020 |
Why?
|
Hemoglobins | 1 | 2014 | 1516 | 0.020 |
Why?
|
Blood | 1 | 2010 | 601 | 0.020 |
Why?
|
Models, Statistical | 1 | 2022 | 5081 | 0.020 |
Why?
|
Pain | 1 | 2022 | 4846 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1096 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 3907 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2014 | 38720 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2007 | 171 | 0.020 |
Why?
|
Benzamides | 1 | 2012 | 1372 | 0.020 |
Why?
|
Swimming | 1 | 2007 | 203 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1905 | 0.020 |
Why?
|
Collagen | 1 | 2015 | 2677 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5915 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3525 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1340 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1797 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6457 | 0.020 |
Why?
|
Fibroblasts | 1 | 2015 | 4196 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2263 | 0.020 |
Why?
|
Wound Healing | 1 | 2015 | 2769 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2912 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 9956 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2012 | 2430 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2016 | 61674 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 7859 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 2936 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2258 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1829 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10968 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12937 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5217 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 2195 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12795 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 16263 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6212 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10385 | 0.010 |
Why?
|
Public Health | 1 | 2011 | 2524 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6562 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2010 | 3263 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 28148 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 74145 | 0.010 |
Why?
|
Body Weight | 1 | 2007 | 4657 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5458 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18337 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15454 | 0.010 |
Why?
|